{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T04:59:00Z","timestamp":1694667540125},"reference-count":32,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A novel, electrochemiluminescence immunoassay that exclusively measures full\u2010length parathyroid hormone (PTH), called Elecsys PTH (1\u201384) assay, is currently under development for clinical use. We measured serum PTH levels using this novel assay, as well as the Elecsys Intact PTH assay and the Whole PTH immunoradiometric assay, in 53 hemodialysis patients who participated in a 52\u2010week clinical trial of cinacalcet. At baseline, serum PTH (1\u201384) levels measured with the Elecsys PTH (1\u201384) assay and those with the Whole PTH assay were comparable, and both values were significantly lower than Elecsys Intact PTH levels. After 52\u2003weeks of cinacalcet treatment, Elecsys PTH (1\u201384) levels and Whole PTH levels decreased significantly by 56% and 60% from baseline, respectively. These results indicate that the Elecsys PTH (1\u201384) assay provides comparable data to the Whole PTH assay for monitoring parathyroid function in patients receiving hemodialysis. Introduction of this novel automated immunoassay would provide more widespread measurements of full\u2010length PTH (1\u201384) in clinical practice.<\/jats:p>","DOI":"10.1111\/j.1744-9987.2011.00928.x","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T17:40:10Z","timestamp":1305913210000},"page":"56-61","source":"Crossref","is-referenced-by-count":3,"title":["Novel Electrochemiluminescence Immunoassay Exclusively for Full\u2010length Parathyroid Hormone during Treatment with Cinacalcet for Secondary Hyperparathyroidism"],"prefix":"10.1111","volume":"15","author":[{"given":"Hisae","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Komaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke TB","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001594"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.12.016"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.374"},{"issue":"113","key":"e_1_2_7_6_2","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD\u2013MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group","year":"2009","journal-title":"Kidney Int"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.11.3923"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinchem\/46.5.697","article-title":"Influence of glomerular filtration rate on intact parathyroid hormone levels in renal failure patients: role of non\u2010(1\u201384) PTH detected by intact PTH assays","volume":"46","author":"Brossard JH","year":"2000","journal-title":"Clin Chem"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full\u2010length human PTH but not amino\u2010terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John MR","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02110310"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2008.00648.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5893.643"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001606"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001599"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.4.605"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27436"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1715-1"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm534"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0243"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00517.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1262-x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007121320"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp578"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.021592"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01391005"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP64069"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm891"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn088"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.114"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00949.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.34519"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00513.x"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.2011.00928.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.2011.00928.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:54:57Z","timestamp":1694631297000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.2011.00928.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":32,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1111\/j.1744-9987.2011.00928.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.2011.00928.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]}}}